TG Therapeutics: Pressure On Briumvi To Perform As Share Price Hits Resistance

400 300 200 D Nov. OGI Sep Aug Jul Jun May Apiruk Seeking Alpha, TradingView The share price of TG was riding high last year following Briumvi's launch and while the management team did not provide revenue guidance during the initial launch period, their comments were (with benefit of hindsight) interpreted as Briumvi performing much better than it, in reality, was. The hard landing happened when the company announced second quarter results in early August 2023, slightly missing the revenue consensus and an ...